Vaccinium arctostaphylos is a traditional medicinal plant in Iran used for the treatment of diabetes mellitus. In our search for antidiabetic compounds from natural sources, we found that the extract obtained from V. arctostaphylos berries showed an inhibitory effect on pan- 
Introduction
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels. One goal of therapy for diabetic patients, especially non-insulin-dependent diabetes mellitus (type 2 diabetes), is the maintenance of normal blood glucose levels after a meal (postprandial hyperglycemia) (Li et al., 2005; Mai and Chuyen, 2007) . A therapeutic approach for decreasing blood glucose level after a meal is to retard the absorption of glucose by inhibition of carbohydrate-hydrolyzing enzymes, such as α-amylase and α-glucosidases. The inhibition of the enzymes signifi cantly decreases the digestion and absorption of carbohydrates, thereby decreasing the postprandial blood glucose levels (Ali et al., 2006; Dewi et al., 2007; Kwon et al., 2006) . Thus, there is a need to develop compounds with enzyme inhibitory activities.
The genus Vaccinium (Ericaceae) comprises nearly 200 species, most of them found in the northern hemisphere (Morazzoni and Bombardelli, 1996) . The genus is represented in Iran only by the species Vaccinium arctostaphylos L. (Wendelbo, 1965) . V. arctostaphylos is a shrub found in the northern forests of Iran between 1600 and 1800 m above sea level and is locally known as "Qaraqat" and/or "Cyah-gileh". V. arctostaphylos is used traditionally as food and for its medicinal values. In traditional Iranian medicine, the decoction from the berries has been used as antidiabetic and antihypertensive agent for a long time (Amin, 1991; Ghahreman, 2001) .
Different parts of V. arctostaphylos have been reported to exhibit various biological activities, such as antioxidant and antimicrobial effects ( Tosun et al., 2004; Taherpour et al., 2008; Koca and Karadeniz, 2009) . However, there is no report on an antihyperglycemic activity and α-amylase inhibitory effect of V. arctostaphylos berries. A bioactivity-guided study of the extract obtained from V. arctostaphylos berries was performed to investigate the α-amylase inhibitory activity of the extract and to isolate the compound responsible for the inhibitory activity.
Material and Methods

Plant material
The ripe berries of V. arctostaphylos were collected from the forest region of Asalem in the north of Iran in August 2002. Voucher specimens were deposited in the herbarium of the Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran (no. 6520 THE).
Extraction, chromatography, and spectroscopy
The berries of the plant were air-dried at room temperature, pulverized, and extracted by mac-eration of 400 g of the berries with methanol/glacial acetic acid/water (70:2:28 v/v/v). The extract was fi ltered, concentrated, and then partitioned against ethyl acetate. The aqueous part was fractionated by repeated descending preparative paper chromatography (PC) on Whatman No. 3MM paper using n-butanol/glacial acetic acid/ water (4:1:5 v/v/v, upper phase) (BAW) and 15% aqueous acetic acid (15% HOAc) as developing solvents. The bands were eluted using methanol/ glacial acetic acid/water (90:5:5 v/v/v), the eluent concentrated, and monitored by descending PC on Whatman No. 1 paper (Glassgen et al., 1992) .
The pure compound was identifi ed on the basis of spectral and chromatographic studies. The UV-Vis spectrum was recorded on a Shimadzu UV-160A spectrophotometer in 0.01 M HCl/ CH 3 OH; the 1 H NMR spectrum was taken on a Bruker Spectrospin 500 spectrometer in CD 3 OD/ CF 3 COOD (5:1), and chemical shifts were recorded as δ values; the positive FAB-MS spectrum was obtained in glycerol/HCl as the matrix by a Finnigan MAT TSQ 700 mass spectrometer. The nature of the sugar moiety in the isolated compound was determined through acid hydrolysis, according to standard methods (Francis et al., 1966) and direct comparison of the moiety with authentic carbohydrates by co-chromatography on Merck cellulose TLC plates.
α-Amylase inhibition test
The α-amylase inhibitory activity was determined using the method described previously (Nickavar et al., 2008) . Briefl y, 1 mL of the porcine pancreatic α-amylase enzyme solution (0.5 IU/mL) in 20 mM phosphate buffer (pH 6.9) was incubated with 1 mL of each test (at various concentrations) for 30 min. The reaction was initiated by adding 1 mL of 0.5% soluble potato starch solution, and the mixture was incubated for 3 min at 25 °C. Then, 1 mL of the colour reagent (96 mM 3,5-dinitrosalicylic acid and 5.31 M sodium potassium tartrate in 2 M sodium hydroxide) was added, and the mixture was placed in a water bath at 85 °C. After 15 min, the reaction mixture was diluted with distilled water, and the absorbance determined at 540 nm. Individual blanks were prepared for correcting the background absorbance. In this case, the colour reagent solution was added prior to the addition of starch solution and the mixture then placed in the water bath immediately. Controls were representative of the 100% enzyme activity. They were conducted in an identical fashion replacing tests with 1 mL of the solvent. Acarbose, a well-known α-amylase inhibitor, was used as positive control. The inhibition percentage of α-amylase was assessed by the following formula:
where A control is the absorbance of each control, and A sample is the net absorbance of each sample. The net absorbance of each sample was calculated as:
where A test is the absorbance of the test, and A blank is the absorbance of each blank.
The I α-amylase (%) for each sample was plotted against the logarithm of sample concentration, and a logarithmic regression curve was established in order to calculate the IC 50 value. The assays were performed in triplicate.
Malvidin-3-O-β-glucoside
UV-Vis: λ max (CH 3 OH/HCl) = 539, 277.5, 215.5 nm; +AlCl 3 (5% AlCl 3 in CH 3 OH): 539, 277.5, 215.5 nm. -E 440 /E vis,max = 23%. 
Results and Discussion
The extract obtained from V. arctostaphylos berries produced a dose-dependent reduction in the α-amylase activity [IC 50 = 1.91 (1.89 -1.94) mg/mL] ( Table I) .
The PC analysis of the aqueous part revealed at least three major compounds. The most active compound of the aqueous part involved in the inhibition of the enzyme had R f = 0.32 and R f = 0.49 with BAW and 15% HOAc, respectively. The chromatographic and spectral data of the compound revealed that it was malvidin-3-O-β-glucoside (Mv-3-glc) (Fig. 1) , and all of its data matched with those reported in the literature (Cabrita and Andersen, 1999) . The compound inhibited α-amylase activity in a dose-dependent manner. The IC 50 value was 0.329 (0.316 -0.342) mM (Table I) . However, the data indicate that malvidin-3-O-β-glucoside is not as potent as the reference inhibitor acarbose [IC 50 = 0.033 (0.031 -0.036) mM].
Generally, the anthocyanins of the genus Vaccinium have received much attention due to their relevant pharmacological properties. Malvidin-3-O-β-glucoside has already been isolated from some species belonging to the genus including V. arctostaphylos (Ballinger et al., 1981 (Ballinger et al., , 1982 Baj et al., 1983; Andersen, 1985 Andersen, , 1987a Andersen, , b, 1989 Gao and Mazza, 1994; Cabrita and Andersen, 1999; Nickavar and Amin, 2004; Grace et al. 2009 ). However, to the best of our knowledge, this is the fi rst report on the inhibitory effect of malvidin-3-O-β-glucoside on α-amylase. 
